BioCentury
ARTICLE | Financial News

Vical raises $33.8M after Phase III miss

September 25, 2010 12:20 AM UTC

Vical Inc. (NASDAQ:VICL) raised $33.8 million through the sale of 15 million shares at $2.25 per share in a follow-on underwritten by Jefferies; Stifel; and Canaccord. Vical proposed the offering late Thursday, when its stock price was $2.87. Vical lost $0.60 (21%) to $2.27 on Friday. ...